History of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis

Scandinavian Journal of Rheumatology

Volumn 45, Issue 2, 2016, Pages 114-117

  Mahmood, M ^a   Wilkinson, J ^b   Manning, J ^c   Herrick, A L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; DNA TOPOISOMERASE; PROSTANOID; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; NUCLEAR PROTEIN; PROSTAGLANDIN; SCL 70 ANTIGEN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; AMPUTATION; ARTICLE; CALCINOSIS; CROSS-SECTIONAL STUDY; DEBRIDEMENT; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SYSTEMIC SCLEROSIS; VERY ELDERLY; AGE; HYPERTENSION, PULMONARY; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PULMONARY FIBROSIS; RISK FACTOR; SCLERODERMA, SYSTEMIC; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMPUTATION; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CALCINOSIS; CROSS-SECTIONAL STUDIES; DEBRIDEMENT; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; ODDS RATIO; PROSTAGLANDINS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84960422604     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2015.1086432     Document Type: Article

References (15)

1. Steen VD, Zeigler GL, Rodnan GP, Medsger TA. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984; 27: 125-31.
2. Akesson A, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol 1989; 28: 281-6.
3. Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A., et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis 2006; 65: 1088-92.
4. Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S., et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology 2010; 49: 1374-82.
5. Bogoch ER, Gross DK. Surgery of the hand in patients with systemic sclerosis: outcomes and considerations. J Rheumatol 2005; 32: 642-8.
6. Steyerberg E. Overfitting and optimism in prediction models. In: Clinical prediction models. New York: Springer-Verlag, 2009: 83-100
7. Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M., et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Ann Rheum Dis 2012; 71: 718-21.
8. Mouthon L, Mestre-Stanislas C, Berezne A, Rannou F, Guilpain P, Revel M., et al. Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 2010; 69: 214-17.
9. Vayssairat M, Hidouche D, Abdoucheli-Baudot N, Gaitz JP. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis 1998; 57: 252-4.
10. Herrick AL, Moore TL, Murray AK, Whidby N, Manning J, Bhushan M., et al. Nailfold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia. Rheumatology 2010; 49: 1776-82.
11. Johnstone EM, Hutchinson CE, Vail A, Chevance A, Herrick AL. Acro-osteolysis in systemic sclerosisis associated with digital ischaemia and with severe calcinosis. Rheumatology 2012; 51: 2234-8.
12. Wigley FM, Wise RA, Miller R, Needleman BW, Spence RJ. Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 688-93.
13. Herrick AL, Haeney M, Hollis S, Jayson MIV. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 1994; 53: 540-2.
14. Koschik RW, Fertig N, Lucas MR, Domsic RT, Medsger TA. Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol 2012; 30 (Suppl 71): S12-6.
15. D'Aoust J, Hudson M, Tatibouet S, Wick J.,. Canadian Scleroderma Research Group, Mahler M, et al. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients. Arthritis Rheumatol 2014; 66: 1608-15.